Effect of OSU6162 (OSU) compared to placebo on the Berliner

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial - The Lancet Oncology

The weird power of the placebo effect, explained - Vox

PDF) Carlsson A, Carlsson ML. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues Clin Neurosci 8: 137-142

Nitya JAYARAM-LINDSTRÖM, Managing Director, PhD, Clinical Neuroscience Karolinska Institutet

Improving somatic health for outpatients with severe mental illness van Hasselt, F.; Loonen, Antonius - PDF Free Download

The placebo effect. (a) Meta-analysis of clinical trials comparing

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial - The Lancet Oncology

Exploratory analysis of treatment effect of OSU6162 (OSU) compared to

The Placebo Effect in Overactive Bladder Syndrome

Pia Steensland's research works Karolinska Institutet, Solna (KI) and other places